Dave is an award-winning business reporter who has authored over 200 articles for New Brunswick Today.
The Acting FDA Commissioner told reporters that half a dozen “cases of a rare and severe type of blood clot” had occurred nationwide in women who were administered the Johnson & Johnson COVID-19 vaccine.Continue Reading
Widely viewed as potentially game-changing, a single-dose COVID-19 vaccine produced by Johnson & Johnson is on track to receive federal approval within weeks.Continue Reading
Using the federal CDBG funding authorized by the CARES Act, the county awarded $1,062,260 in grants for job retention and creation to local establishments with no more than ten employees and net incomes of $100,000 or less per year.Continue Reading
In May, the New Brunswick-based corporation said it “will wind down the commercialization of talc-based Baby Powder in the US and Canada in the coming months,” adding that “existing inventory will continue to be sold through retailers until it runs out.” But that’s not enough, says “Black Women for Wellness,” one of the many advocacy groups pushing for J&J to stop selling its baby powder worldwide.Continue Reading
NEW BRUNSWICK, NJ—Nine drug company CEO’s including Johnson & Johnson’s Alex Gorsky signed a September 8 pledge to continue making the safety of vaccinated individuals the top priority as theyContinue Reading
Johnson & Johnson (J&J) said on August 19 it agreed to purchase drugmaker Momenta Pharmaceuticals Inc. for about $6.5 billion.Continue Reading
More desperately needed financial relief for New Jersey’s small businesses was made official on July 28.Continue Reading
